QGP-1人胰腺癌细胞

QGP-1、QGP-1、QGP-1细胞、QGP-1细胞、QGP-1人胰腺癌细胞

Comments    
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Part of: NCI RAS program mutant KRAS cell line panel.
Population: Japanese.
Doubling time: ~3.5 days (PubMed=7227711); 61 hours (PubMed=25984343); 1.6 +- 0.3 days (PubMed=29330294); 40-50 hours (Note=Lot 04152003), ~2 days (Note=Lot 02162009), ~42 hours (Note=Lot 04112012), ~74 hours (Note=Lot 05312016) (JCRB=JCRB0183).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Array-based CGH.
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: shRNA library screening.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Misspelling: QGP; CGH-DB=9375-4; GEO=GSM600373.
Misspelling: QCP-1; DOI=10.5772/30884.
Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
Cell type: Pancreatic delta cell; CL=CL_0000173.

PubMed=7227711; DOI=10.20772/cancersci1959.71.5_596

Kaku M., Nishiyama T., Yagawa K., Abe M.

Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma.

Gann 71:596-601(1980)

 

PubMed=6205259; DOI=10.1016/0161-5890(84)90028-2

Kuroki M., Kuroki M., Ichiki S., Matsuoka Y.

Identification and partial characterization of the unglycosylated peptide of carcinoembryonic antigen synthesized by human tumor cell lines in the presence of tunicamycin.

Mol. Immunol. 21:743-746(1984)

 

PubMed=1971195

Iguchi H., Hayashi I., Kono A.

A somatostatin-secreting cell line established from a human pancreatic islet cell carcinoma (somatostatinoma): release experiment and immunohistochemical study.

Cancer Res. 50:3691-3693(1990)

 

PubMed=8426738

Kalthoff H., Schmiegel W.H., Roeder C., Kasche D., Schmidt A., Lauer G., Thiele H.-G., Honold G., Pantel K., Riethmuller G., Scherer E., Maurer J., Maacke H., Deppert W.

p53 and K-RAS alterations in pancreatic epithelial cell lesions.

Oncogene 8:289-298(1993)

 

PubMed=21607521; DOI=10.3892/or.1.6.1223

Iguchi H., Morita R., Yasuda D., Takayanagi R., Ikeda Y., Takada Y., Shimazoe T., Nawata H., Kono A.

Alterations of the p53 tumor-suppressor gene and ki-ras oncogene in human pancreatic cancer-derived cell-lines with different metastatic potential.

Oncol. Rep. 1:1223-1227(1994)

 

PubMed=11169959; DOI=10.1002/1097-0215(200002)9999:9999<::AID-IJC1049>3.0.CO;2-C

Sirivatanauksorn V., Sirivatanauksorn Y., Gorman P.A., Davidson J.M., Sheer D., Moore P.S., Scarpa A., Edwards P.A.W., Lemoine N.R.

Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping.

Int. J. Cancer 91:350-358(2001)

 

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662

Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Cancer Res. 70:2158-2164(2010)

 

DOI=10.5772/30884

Ruckert F., Pilarsky C., Grutzmann R.

Establishment of primary cell lines in pancreatic cancer.

(In book chapter) Pancreatic cancer. Molecular mechanism and targets; Srivastava S. (eds.); pp.259-274; InTechOpen; London; United Kingdom (2012)